Skip to main content
. 2020 Nov 24;2020:8827920. doi: 10.1155/2020/8827920

Figure 1.

Figure 1

The expression of GJA1 and its association with clinicopathological parameters based on TCGA data: (a) histology type; (b) FIGO stage of all CC patients; (c) impact of GJA1 expression on OS in all CC patients; (d) FIGO stage of SCC patients; (e) impact of GJA1 expression on OS in all SCC patients; (f) impact of GJA1 expression on OS in patients with FIGO stage ≤ IIA2; (g) impact of GJA1 expression on OS in patients with FIGO stage ≥ IIB. TCGA: The Cancer Genome Atlas; FIGO: the International Federation of Gynecology and Obstetrics; CC: cervical cancer; OS: overall survival; SCC: squamous cell carcinoma; ACC: adenomas and adenocarcinomas; GJA1: gap junction protein alpha 1; ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001.